Received by email:

File: 07272016 Alliance NR -  Pharmagreen LOI update.docx

/

ALLIANCE GROWERS CORP.

NEWS RELEASE


ALLIANCE GROWERS UPDATES PROGRESS WITH WFS PHARMAGREEN

-Tommy Chong Endorsement and Cana Companion Included in Potential Alliance

July 27, 2016 - Vancouver, B.C. - Alliance Growers Corp. (CSE: ACG) ("Alliance Growers" or the "Company") is pleased t
--->o report that, further to its press release of June 30, 2016, the Letter of Intent with WFS Pharmagreen Inc. ("Pharmag
--->reen") on obtaining an exclusive license for the commercialization of the "Chibafreen Invitro Plant Production System"
---> in Canada is progressing much better than expected and has led to additional joint business opportunities to be explo
--->red.  The Exclusive License from Pharmagreen covers the marketing, distribution and sales of all present and future Ti
--->ssue Culture plantlet products utilizing the proprietary "Chibafreen Invitro Plant Production System" for the jurisdic
--->tion of Canada.  Alliance has advanced on its discussions regarding additional joint business interests and opportunit
--->ies with Pharmagreen, including a potential full merger of Pharmagreen and Alliance Growers, subject to continued exte
--->nsive due diligence and analysis.
Growing Cannabis using tissue culture propagation, specifically the "Chibafreen Invitro Plant Production System", assu
--->res consistent composition and purity of each plantlet for the growers, regardless of where and by whom the plants are
---> cultivated. Licensing Pharmagreen's proprietary process provides tremendous advantages including rapid and ef{{fi &#64
--->257;} fi}cient growth of plants that will result in 30-50% shorter production period. Plantlets that are produce
--->d under uniformly controlled environment in the protected area are free from pest insects/pathogens and the disturbanc
--->e of outside weather.  Additionally, such plantlets are of very high quality, disease free and geared for optimal grow
--->th. Each plantlet will always have the same genetic makeup as its parent stock.
Commenting on the business development opportunities, Dennis Petke, Alliance Growers' President and CEO stated, "We co
--->uld not be more impressed, the more we delve into the breadth and depth of Pharmagreen's innovations, that their techn
--->ology will give Alliance the ability to generate tremendous cash flow from the burgeoning Cannabis industry, as well a
--->s the agriculture industry in general. In addition to the Tissue Culture plantlet products, we are impressed with the 
--->development and rapid growth of Pharmagreen's subsidiary, Canna Companion, and the strong involvement of celebrity Tom
--->my Chong".
While moving toward the execution of a formal license agreement, both Alliance and Pharmagreen agree to possible furth
--->er development of a "Full Spectrum DNA Botany Lab", which would be the only such lab facility in Western Canada.  A un
--->ique blend of clean room lab facilities including a botanical oils extraction lab would be built under the heading of 
--->"Botany Center". Licensing opportunities for the "Botany Center" for the UK and European Union are subject to further 
--->negotiations and terms.
From a monetary perspective, Pharmagreen's business initiatives are on the cutting edge of functional innovations that
---> not only bear significant profit margins, but also provide a model of micro propagation technology that can be applie
--->d across the entire agriculture industry on a mass production scale with "Chibafreen Invitro Plant Production System".
--->  To put this in perspective, potential revenue from this system is only limited by the size of the production facilit
--->y. 
About Alliance Growers  

Alliance Growers Corp (ACG: CSE) is a diversified cannabis company driven by the Company's 'Four Pillars' Organization
---> Plan - MMPR cannabis production facilities, distribution network, consumer products, and research and development. Fo
--->r further information please visit the Company's corporate website at www.alliancegrowers.com or the Company's profile
---> at www.sedar.com.
If you would like to be added to Alliance Grower's news distribution list, please send your email address to newslette
--->r@alliancegrowers.com 
About Pharmagreen
WFS Pharmagreen Inc. is a private company located in Mission, B.C. that is in the business of manufacturing and market
--->ing cannabis-hemp based products for animals and owns the exclusive international rights to all present and future Can
--->na Companion formulations and products. The Company's executive management team and its advisory committee are compose
--->d of a significant mix of professionals that have been carefully gleaned from the fields of private and public company
---> management; veterinary science; human medical science; marketing, branding and business development capped with unpar
--->alleled academic and celebrity endorsement. The Company's animal products developed under its 100%  owned subsidiary C
--->anna Companion Products, Inc based in Washington State, U.S.A., operates a 5,000 sq. ft. facility for product formulat
--->ion,, fulfillment and customer care in Monroe, Washington  This center supports its U.S. based sales for all levels, d
--->istributors, dealers, and e-commerce of the Canna Companion products via www.cannacompanionusa.com . 
On behalf of the board of directors of 
ALLIANCE GROWERS CORP. 
"Dennis Petke" 
Dennis Petke, 
CEO 

For more information contact:

Dennis Petke 
CEO
Tel: 778-331-4266
DennisPetke@alliancegrowers.com 

Rob Grace
VP Corporate Development
Tel: 778-998-5431
RobGrace@alliancegrowers.com 

FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable
---> securities laws. These statements relate to future events or future performance. All statements other than statements
---> of historical fact may be forward-looking statements or information. More particularly and without limitation, the ne
--->ws release contains forward-looking statements and information relating to the use of proceeds of the Financing, as we
--->ll as the Company's corporate strategy. The forward-looking statements and information are based on certain key expect
--->ations and assumptions made by management of the Company, including, without limitation, the Company's ability to carr
--->y out its business plan following the issuance of the required licenses by Health Canada. Although management of the C
--->ompany believes that the expectations and assumptions on which such forward-looking statements and information are bas
--->ed are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assu
--->rance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current exp
--->ectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such s
--->tatements and information may not be appropriate for other purposes, such as making investment decisions. Since forwar
--->d-looking statements and information address future events and conditions, by their very nature they involve risks and
---> uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and
---> risks. These include, but are not limited to, the Company's ability to identify and complete additional suitable acqu
--->isitions to further the Company's growth as well as risks associated with the medical marijuana industry in general, s
--->uch as operational risks in development and production delays or changes in plans with respect to development projects
---> or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, 
--->production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets;
---> environmental risks; competition; incorrect assessment of the value of the potential market; ability to access suffic
--->ient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes
---> in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not plac
--->e undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers 
--->are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no un
--->dertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of 
--->new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securiti
--->es Exchange. The forward-looking statements or information contained in this news release are expressly qualified by t
--->his cautionary statement.